Levonorgestrel 52 mg intrauterine device placement without uterine sounding: A feasibility study. Brown JA, Yazdani S, Economou N, Rankin HA, et al. Contraception 2025;142:110722.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brown JA, Yazdani S, Economou N, Rankin HA, et al. Levonorgestrel 52 mg intrauterine device placement without uterine sounding: A feasibility study. Contraception 2025;142:110722.
PMID: 39368691